ロード中...

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis

Sodium glucose transporter 2 (SGLT2) inhibitors are a recently developed class of drug that have been approved for use in type 2 diabetes. Their unique extra-pancreatic glucuretic mode of action has encouraged their usage in type 1 diabetes as well. At the same time, reports of pseudo ketoacidosis a...

詳細記述

保存先:
書誌詳細
出版年:Indian J Endocrinol Metab
主要な著者: Kalra, Sanjay, Sahay, Rakesh, Gupta, Yashdeep
フォーマット: Artigo
言語:Inglês
出版事項: Medknow Publications & Media Pvt Ltd 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481661/
https://ncbi.nlm.nih.gov/pubmed/26180770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.157859
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!